U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Bleeding disorder, platelet-type, 24(BDPLT24)

MedGen UID:
1785711
Concept ID:
C5543280
Disease or Syndrome
Synonym: GLANZMANN THROMBASTHENIA-LIKE WITH MACROTHROMBOCYTOPENIA 2
 
Gene (location): ITGB3 (17q21.32)
 
Monarch Initiative: MONDO:0030996
OMIM®: 619271

Definition

Platelet-type bleeding disorder-24 (BDPLT24) is an autosomal dominant form of congenital macrothrombocytopenia associated with platelet anisocytosis. It is a disorder of platelet production. Affected individuals may have no or only mildly increased bleeding tendency. In vitro studies show mild platelet functional abnormalities (summary by Kunishima et al., 2011 and Nurden et al., 2011). For a discussion of genetic heterogeneity of Glanzmann thrombasthenia-like with macrothrombocytopenia, see 187800. [from OMIM]

Clinical features

From HPO
Menorrhagia
MedGen UID:
44358
Concept ID:
C0025323
Pathologic Function
Prolonged and excessive menses at regular intervals in excess of 80 mL or lasting longer than 7 days.
Thrombocytopenia
MedGen UID:
52737
Concept ID:
C0040034
Disease or Syndrome
A reduction in the number of circulating thrombocytes.
Increased mean platelet volume
MedGen UID:
853131
Concept ID:
C1096367
Finding
Average platelet volume above the upper limit of the normal reference interval.
Abnormal bleeding
MedGen UID:
264316
Concept ID:
C1458140
Pathologic Function
An abnormal susceptibility to bleeding, often referred to as a bleeding diathesis. A bleeding diathesis may be related to vascular, platelet and coagulation defects.
Platelet anisocytosis
MedGen UID:
810926
Concept ID:
C1739105
Pathologic Function
Abnormally increased variability in the size of platelets.
Impaired ristocetin-induced platelet aggregation
MedGen UID:
868749
Concept ID:
C4023154
Pathologic Function
Abnormal response to ristocetin as manifested by reduced or lacking aggregation of platelets upon addition of ristocetin.
Impaired arachidonic acid-induced platelet aggregation
MedGen UID:
868750
Concept ID:
C4023155
Pathologic Function
Abnormal response to arachidonic acid as manifested by reduced or lacking aggregation of platelets upon addition of arachidonic acid.
Impaired collagen-induced platelet aggregation
MedGen UID:
870264
Concept ID:
C4024703
Finding
Abnormal response to collagen or collagen-mimetics as manifested by reduced or lacking aggregation of platelets upon addition collagen or collagen-mimetics.
Impaired epinephrine-induced platelet aggregation
MedGen UID:
870285
Concept ID:
C4024727
Finding
Abnormal response to epinephrine as manifested by reduced or lacking aggregation of platelets upon addition of epinephrine.
Impaired ADP-induced platelet aggregation
MedGen UID:
870824
Concept ID:
C4025282
Finding
Abnormal platelet response to ADP as manifested by reduced or lacking aggregation of platelets upon addition of ADP.

Recent clinical studies

Etiology

Kreuz W, Mentzer D, Becker S, Scharrer I, Kornhuber B
Haemostasis 1994 Sep-Oct;24(5):304-10. doi: 10.1159/000217118. PMID: 7843642
Bloom AL
Mayo Clin Proc 1991 Jul;66(7):743-51. doi: 10.1016/s0025-6196(12)62088-6. PMID: 2072762

Diagnosis

Kreuz W, Mentzer D, Becker S, Scharrer I, Kornhuber B
Haemostasis 1994 Sep-Oct;24(5):304-10. doi: 10.1159/000217118. PMID: 7843642

Therapy

Kreuz W, Mentzer D, Becker S, Scharrer I, Kornhuber B
Haemostasis 1994 Sep-Oct;24(5):304-10. doi: 10.1159/000217118. PMID: 7843642

Prognosis

Kreuz W, Mentzer D, Becker S, Scharrer I, Kornhuber B
Haemostasis 1994 Sep-Oct;24(5):304-10. doi: 10.1159/000217118. PMID: 7843642

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...